ÂÜÀòÂÒÂ×

Rupesh Amin is a seasoned professional in the field of cancer immunotherapy, currently serving as Senior Director for the CAR T Pipeline at Outpace Bio since March 2023. Prior to this role, Rupesh held the position of Director for the Advanced Technologies Group at Century Therapeutics, LLC, where work focused on engineering allogeneic T and NK cells using the iPSC platform. Rupesh's experience includes serving as Associate Director at Bristol-Myers Squibb, leading initiatives to enhance CAR T cell therapies, and as a Senior Scientist at Juno Therapeutics, Inc., focused on developing innovative cancer immunotherapies. Early research contributions were made during postdoctoral fellowships at Fred Hutch and UC Berkeley, where Rupesh explored stem cell mechanisms and B-cell development, respectively. Rupesh Amin holds a Ph.D. in Molecular Biology/Immunology from the University of California, Berkeley, and a B.S. in Biochemistry and Molecular Biology from the University of Arizona.